DIRS.INFO The most relevant business & tech news

☆ Tyler Blevins, estrella de los videojuegos, revela que le han diagnosticado cáncer de piel
▼ + stars: | 2024-03-27 | by ( Johnny Diaz | ) www.nytimes.com time to read: 1 min

Thank you for your patience while we verify access. Already a subscriber? Want all of The Times?

Organizations: The

☆ KeyBanc thinks newly-public Israeli beauty stock is underappreciated in healthcare technology
▼ + stars: | 2023-08-15 | by ( Pia Singh | ) www.cnbc.com time to read: +2 min

Investors are overlooking Oddity Tech , which is poised to become a leader in the growing digital beauty and wellness market, according to KeyBanc. Analyst Scott Schoenhaus initiated coverage of the Israeli beauty company with an overweight rating and assigned a price target of $60, suggesting shares stand to gain more than 29% in the next 12 months. "We see ODD in the early stages of its growth story, with near-term tailwinds from its ongoing disruption of beauty and wellness end markets but longer-term growth opportunities that can be unlocked given its unique, differentiated technology," Schoenhaus wrote in a Monday note. Oddity's use of its "nascent hyperspectral technology" and a company-owned biotechnology asset — both powered by AI — will lead to novel beauty and wellness treatments, KeyBanc said. Oddity's legacy IL Makiage brand comprises about 2% of the total beauty market, the note said.

Persons: Scott Schoenhaus, Schoenhaus, —, KeyBanc, Goldman Sachs, Morgan Stanley, — CNBC's Michael Bloom Organizations: Allen, Co Locations: Israeli

☆ Oddity will start trading after pricing IPO above range — here's what the beauty and tech company does
▼ + stars: | 2023-07-19 | by ( Gabrielle Fonrouge | In Gabrielle-Fonrouge | ) www.cnbc.com time to read: +4 min

In the three months ended March 31, the company saw $165.7 million in revenue, up from $90.4 million in the year-ago period. It reported net income of $19.6 million, or 35 cents a share, compared with about $3 million, or 5 cents a share, a year earlier. In fiscal 2022, Oddity brought in $324.5 million in sales and saw net income of $21.7 million, or 39 cents a share. In the year prior, the retailer saw $222.6 million in revenue and net income of $13.9 million, or 26 cents a share. In 2020, it saw $110.6 million in sales and net income of $11.7 million, or 22 cents a share.

Persons: Oran Holtzman, Holtzman, Shiran Holtzman, Lindsay Drucker Mann, Goldman Sachs Organizations: Tech, Nasdaq, CNBC, Goldman, Israeli Defense Forces Locations: U.S

☆ AI hype embellishes Il Makiage IPO
▼ + stars: | 2023-07-06 | by ( Anita Ramaswamy | ) www.reuters.com time to read: +3 min

NEW YORK, July 6 (Reuters Breakingviews) - Oddity Tech has a sparkly foundation for its upcoming initial public offering. The Israeli beauty company home to the Il Makiage and SpoiledChild brands is highlighting the artificial intelligence behind its makeup and machine learning algorithms that help consumers pick the right shades. These features should help put a dewy gloss on the valuation before the hype eventually fades. His company sells concealers and eye shadows directly to shoppers online and touts that its technology teams account for 40% of headcount. AI also powers Revela, a biotechnology firm it bought in April that develops new molecules for cosmetics and skincare.

Persons: Boss Oran Holtzman, Revela, It’s, Estee Lauder, Child, Goldman Sachs, Morgan Stanley, Jeffrey Goldfarb, Sharon Lam Organizations: YORK, Reuters, Nasdaq, Coty, Tech, Allen, Co, Thomson Locations: Israeli, Cava

☆ Il Makiage parent Oddity buys biotech startup Revela to design new molecules for beauty products
▼ + stars: | 2023-04-27 | by ( Gabrielle Fonrouge | ) www.cnbc.com time to read: +2 min

Oddity is buying startup Revela for $76 million, its largest acquisition to date, and is putting another $25 million toward building Oddity Labs in Boston. The merger will bring to Oddity a team of scientists tasked with creating brand-new molecules, using artificial intelligence, that can be used in its cosmetics brands and future lines. AI-based molecule discovery is a common tool used in the pharmaceutical industry to create new drugs, but it isn't widely used in the beauty and wellness industry. Legacy brands have long relied on building products using proprietary formulations with a similar set of active ingredients, such as retinol, hyaluronic acid and peptides. "With this acquisition, we are using biologics to bring game-changing, science-backed beauty and wellness products to the market and to our users.

☆ Zece moduri în care coronavirusul a schimbat economia mondială pentru totdeauna
▼ + stars: | 2021-01-01 | by ( ) www.jurnal.md time to read: +5 min

Economia mondială este pe drumul către recuperare, iar vaccinurile ar trebui să accelereze acest proces în 2021. Guvernele vor juc un rol mai mare în vieţile cetăenilor, cheltuind şi deţinând mai mulţi bani. Rol sporit al statuluiContractul dintre societate şi stat a fost rescris din mers. Monitorizarea de către autorităţi a circulaţiei oamenilor şi plata de către acestea a salariilor lor când angajatorii nu mai pot face acest lucru a devenit ceva obişnuit. Cu vacanţele date peste cap şi evenimente ca festivaluri şi concerte anulate, tendinţa consumatorilor de a pune accent pe experienţe în detrimentul bunurilor a fost întreruptă.

Persons: Coronavirusul Organizations: $ Locations: QE, China

☆ Când Isus nu e Hristos. Evanghelia după Liiceanu
▼ + stars: | 2020-05-26 | by ( Mihail Neamtu | ) adevarul.ro time to read: +9 min

De aici şi tristeţea noastră, ba chiar dezamăgirea şi gustul amar: deşi scrisă îngrijit, ultima carte a lui Gabriel Liiceanu e mai puţin o meditaţie despre Salvator Mundi, cât o răfuială cu scăderile, neputinţele sau erorile creştinismului instituţional. Nici la acest volum Gabriel Liiceanu nu simte nevoia să facă vreo referinţă. Dincolo însă de pedanteria obiecţiilor academice, îi reproşăm autorului altceva: faptul că n-a înţeles că, vrei, nu vrei, atunci când vorbeşti despre Iisus faci teologie. Gabriel Liiceanu accesează un Isus altfel — un personaj special, dezvăluit filozofului prin mecanisme hermeneutice străine „habotnicilor”, „pocăiţilor” sau „pupătorilor de moaşte” (cum e la modă să fie numiţi creştinii în lumea bună). De ce tocmai Iisus a afirmat: „Înainte de Avraam, «Eu sunt... »” – iată un enunţ de-o greutate ontologică lipsită de răspuns din partea filozofului.

Persons: Constantin Noica, Emil Cioran, Alexandru Paleologu, Nicolae Steinhardt, Monica Lovinescu, Virgil Ierunca, Liiceanu, Alvin Plantinga, Anthony Flew, Iisus, Noica, Andrei Pleşu, . Patapievici, Hristos, îşi, Confesorul, Rabbi Yeshoua, Gabriel, Rainer Maria Rilke, Paul Claudel, Iosif, Toma, Andrei, Petru, Lazăr, Zaheu, creştinătate, Dumnezeu, Gabriel Liiceanu, Salvator Mundi, Platon, Heidegger, Giordano Bruno, Galileo Galilei, Socrate, Ioan, Pavel, Iacov, Loyola, Kant, Paul Ricœur, Jean - Luc Marion, Epictet, Edward Gibbon, Arie, Eusebiu al, Atanasie al Alexandriei, Alois Grillmeier, R.P . Hanson, Henry Chadwick, Rowan Williams, R.P ., John Behr, Ioan Ică Jr, Isus, Avraam, Moise Organizations: Universitatea din, R.P . Vaggione Locations: Învecinarea, României, Galileea, Persiei, scăderile, Universitatea din Bucureşti, Niceea

Search resuls for: "Revela"

7 mentions found